Reply: Optimizing Helicobacter pylori eradication and cardiovascular risk assessment in long-term aspirin users: Methodological perspective

We thank Yu et al published in the World Journal of Gastroenterology, for their commentary on our study of Helicobacter pylori eradication in chronic low-dose aspirin users.They commend our real-world cohort design and histopathological integration.Their suggestions focus on optimizing eradication protocols, refining mechanistic interpretation of cardiovascular outcomes, and targeting surveillance strategies.We address each point below.Our eradication rate of 51.9% reflects real-world effectiveness in a high-resistance region and compares favorably with local data.Our composite cardiovascular endpoint was pre-specified and clinically actionable, and our findings remained robust after adjustment for baseline multivessel coronary artery disease and in an E-value sensitivity analysis.Our study was not designed to test the specific mechanistic pathways proposed, and we welcome future research incorporating serial biomarkers and aspirin dosage stratification.Our findings remain hypothesisgenerating, and we provide a foundation for prospective studies.

Authors

Publication Details

Journal
World Journal of Gastroenterology
Published
2026-11-16
DOI
https://doi.org/10.3748/wjg.128169
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reply: Optimizing Helicobacter pylori eradication and cardiovascular risk assessment in long-term aspirin users: Methodological perspective

Amira AA Othman
1 links
World Journal of Gastroenterology
Helicobacter pylori-related gastroenterology studies
article

Reply: Optimizing Helicobacter pylori eradication and cardiovascular risk assessment in long-term aspirin users: Methodological perspective

Amira AA Othman
article en

Abstract

We thank Yu et al published in the World Journal of Gastroenterology, for their commentary on our study of Helicobacter pylori eradication in chronic low-dose aspirin users.They commend our real-world cohort design and histopathological integration.Their suggestions focus on optimizing eradication protocols, refining mechanistic interpretation of cardiovascular outcomes, and targeting surveillance strategies.We address each point below.Our eradication rate of 51.9% reflects real-world effectiveness in a high-resistance region and compares favorably with local data.Our composite cardiovascular endpoint was pre-specified and clinically actionable, and our findings remained robust after adjustment for baseline multivessel coronary artery disease and in an E-value sensitivity analysis.Our study was not designed to test the specific mechanistic pathways proposed, and we welcome future research incorporating serial biomarkers and aspirin dosage stratification.Our findings remain hypothesisgenerating, and we provide a foundation for prospective studies.

World Journal of Gastroenterology
Good health and well-being
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon